AI-Driven Innovation Reshapes Vaccine Adjuvant Discovery as Investment Surges Across Public and Private Sectors

Summary

Article discusses AI-driven innovation reshaping vaccine adjuvant discovery with increased investment across public and private sectors. No specific clinical trial data, financial results, or regulatory catalysts are mentioned.